世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

研究用抗体・試薬の世界市場:製品別(試薬、抗体)、形態別(モノクローナル抗体、ポリクローナル抗体、組み換え抗体)、供給源別(マウス、ウサギ、その他)、技術別(ウェスタンブロッティング、フローサイトメトリ、酵素結合免疫吸着測定、免疫組織化学、免疫蛍光、免疫沈降法、その他の技術)、用途別(プロテオミクス、医薬品開発、ゲノム)、エンドユーザー別(医薬品・バイオテクノロジー産業、学術・研究機関、受託研究機関)、地域別(北米、中南米、欧州、アジア太平洋、中東、アフリカ) - 2023年から2033年まで


Global Research Antibodies and Reagents Market by Product (Reagent, Antibodies), by Form (Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies), by Source (Mice, Rabbit, Other Sources), by Technologies (Western Blotting, Flow Cytometry, Enzyme-linked, Immunosorbent Assay, Immunohistochemistry, Immunofluorescence, Immunoprecipitation, Other Technologies), by Application (Proteomics, Drug Development, Genomics), by End User (Pharmaceutical & Biotechnologies Industries, Academic & Research Institutions, Contract Research Organizations), by Region (North America, Latin America, Europe, Asia- Pacific, Middle East, and Africa) - 2023 to 2033

研究用抗体と試薬の市場 - レポートのスコープ TMRの調査レポート「世界の研究用抗体・試薬市場」は、2023年から2033年までの予測期間における市場の指標について貴重な洞察を得るために、過去だけでなく現在の... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
Transparency Market Research
トランスペアレンシーマーケットリサーチ
2023年3月30日 US$5,795
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
174 英語

 

サマリー

研究用抗体と試薬の市場 - レポートのスコープ
TMRの調査レポート「世界の研究用抗体・試薬市場」は、2023年から2033年までの予測期間における市場の指標について貴重な洞察を得るために、過去だけでなく現在の成長動向や機会も調査しています。本レポートでは、2023年を基準年、2033年を予測年として、2017年から2033年までの期間における世界の研究用抗体および試薬市場の収益を提供します。また、2023年から2033年までの世界の研究用抗体および試薬市場の複合年間成長率(CAGR %)を掲載しています。

本レポートは、広範な調査を経て作成されました。一次調査では、主要なオピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。二次調査では、主要企業の製品資料、年次報告書、プレスリリース、関連文書などを参照し、抗体・試薬市場を把握しました。

また、インターネット上の情報源や政府機関、ウェブサイト、業界団体の統計データも二次調査の対象とした。アナリストは、トップダウンアプローチとボトムアップアプローチを組み合わせて、世界の研究用抗体および試薬市場のさまざまな属性を調査しました。

本レポートには、調査範囲に含まれる様々なセグメントの成長動向のスナップショットとともに、詳細なエグゼクティブサマリーが含まれています。さらに、世界の研究用抗体および試薬市場における競争ダイナミクスの変化にも光を当てています。これらは、既存の市場関係者だけでなく、世界の研究用抗体および試薬市場への参入に関心を持つ企業にとっても貴重なツールとなります。

本レポートは、世界の研究用抗体および試薬市場の競争環境について掘り下げています。世界の研究用抗体および試薬市場で活動する主要企業が特定され、これらの各企業は様々な属性でプロファイルされています。会社概要、財務状況、最近の動向、SWOTは、本レポートで紹介されている世界の研究用抗体および試薬市場のプレーヤーの属性です。

世界の研究用抗体および試薬市場レポートで回答された主要な質問
- 予測期間中、全地域における研究用抗体および試薬の売上/収益はどの程度か?
- 世界の研究用抗体および試薬市場におけるビジネスチャンスは何か?
- 市場の主な促進要因、阻害要因、機会、脅威は何か?
- 予測期間中に最も速いCAGRで拡大するのはどの地域市場か?
- 2033年に世界で最も高い収益を上げると予測されるセグメントは?
- 予測期間中に最も高いCAGRで拡大すると予測されるセグメントはどこか?
- 世界市場で事業展開している各社の市場ポジションは?

研究用抗体・試薬市場 - 研究目的と研究アプローチ
世界の研究用抗体および試薬市場に関する包括的なレポートは、まず概要から始まり、次に研究の範囲と目的について説明しています。本レポートでは、本調査の目的、市場で活動する主要ベンダーや販売業者、製品の承認に関する規制シナリオについて詳細に解説しています。

読みやすさを考慮し、本レポートは章立てでまとめられ、各セクションはより小さなものに分割されています。本レポートは、グラフと表が適切に配置された包括的なコレクションで構成されています。主要セグメントの実績値と予測値を図式化し、読者に視覚的に訴えかけています。また、過去と予測期間終了時の主要セグメントの市場シェアを比較することも可能です。

本レポートでは、世界の研究用抗体・試薬市場を製品、エンドユーザー、地域の観点から分析しています。各基準の主要セグメントを詳細に調査し、2033年末時点の各セグメントごとの市場シェアを掲載しています。このような貴重な洞察により、市場関係者は、世界の研究用抗体および試薬市場への投資について、情報に基づいたビジネス上の意思決定を行うことができます。

ページTOPに戻る


目次

1. Executive Summary
    1.1. Global Market Outlook
    1.2. Demand-side Trends
    1.3. Supply-side Trends
    1.4. Technology Roadmap Analysis
    1.5. Analysis and Recommendations
2. Market Overview
    2.1. Market Coverage / Taxonomy
    2.2. Market Definition / Scope / Limitations
3. Market Background
    3.1. Market Dynamics
        3.1.1. Drivers
        3.1.2. Restraints
        3.1.3. Opportunity
        3.1.4. Trends
    3.2. Scenario Forecast
        3.2.1. Demand in Optimistic Scenario
        3.2.2. Demand in Likely Scenario
        3.2.3. Demand in Conservative Scenario
    3.3. Opportunity Map Analysis
    3.4. Investment Feasibility Matrix
    3.5. PESTLE and Porter’s Analysis
    3.6. Regulatory Landscape
        3.6.1. By Key Regions
        3.6.2. By Key Countries
    3.7. Regional Parent Market Outlook
4. Global Research Antibodies & Reagents Market Analysis 2018-2022 and Forecast, 2023-2033
    4.1. Historical Market Size Value (US$ Million) Analysis, 2018-2022
    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023-2033
        4.2.1. Y-o-Y Growth Trend Analysis
        4.2.2. Absolute $ Opportunity Analysis
5. Global Research Antibodies & Reagents Market Analysis 2018-2022 and Forecast 2023-2033, By Product
    5.1. Introduction / Key Findings
    5.2. Historical Market Size Value (US$ Million) Analysis By Product, 2018-2022
    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2023-2033
        5.3.1. Reagent
            5.3.1.1. Media & Sera
            5.3.1.2. Stains & Dyes
            5.3.1.3. Fixatives
            5.3.1.4. Buffers
            5.3.1.5. Solvents
            5.3.1.6. Enzymes
            5.3.1.7. Probes
            5.3.1.8. Other Reagents
        5.3.2. Antibodies
            5.3.2.1. Primary Antibodies
            5.3.2.2. Secondary Antibodies
    5.4. Y-o-Y Growth Trend Analysis By Product, 2018-2022
    5.5. Absolute $ Opportunity Analysis By Product, 2023-2033
6. Global Research Antibodies & Reagents Market Analysis 2018-2022 and Forecast 2023-2033, By Form
    6.1. Introduction / Key Findings
    6.2. Historical Market Size Value (US$ Million) Analysis By Form, 2018-2022
    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Form, 2023-2033
        6.3.1. Monoclonal Antibodies
        6.3.2. Polyclonal Antibodies
        6.3.3. Recombinant Antibodies
    6.4. Y-o-Y Growth Trend Analysis By Form, 2018-2022
    6.5. Absolute $ Opportunity Analysis By Form, 2023-2033
7. Global Research Antibodies & Reagents Market Analysis 2018-2022 and Forecast 2023-2033, By Source
    7.1. Introduction / Key Findings
    7.2. Historical Market Size Value (US$ Million) Analysis By Source , 2018-2022
    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Source , 2023-2033
        7.3.1. Mice
        7.3.2. Rabbit
        7.3.3. Other Sources
    7.4. Y-o-Y Growth Trend Analysis By Source , 2018-2022
    7.5. Absolute $ Opportunity Analysis By Source , 2023-2033
8. Global Research Antibodies & Reagents Market Analysis 2018-2022 and Forecast 2023-2033, By Technology
    8.1. Introduction / Key Findings
    8.2. Historical Market Size Value (US$ Million) Analysis By Technology, 2018-2022
    8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Technology, 2023-2033
        8.3.1. Weatern Blotting
        8.3.2. Flow Cytometry
        8.3.3. Enzyme-linked Immunosorbent Assay
        8.3.4. Immunohistochemistry
        8.3.5. Immunofluorescence
        8.3.6. Immunoprecipitation
        8.3.7. Other Technologies
    8.4. Y-o-Y Growth Trend Analysis By Technology, 2018-2022
    8.5. Absolute $ Opportunity Analysis By Technology, 2023-2033
9. Global Research Antibodies & Reagents Market Analysis 2018-2022 and Forecast 2023-2033, By Application
    9.1. Introduction / Key Findings
    9.2. Historical Market Size Value (US$ Million) Analysis By Application, 2018-2022
    9.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2023-2033
        9.3.1. Proteomics
        9.3.2. Drug Development
        9.3.3. Genomics
    9.4. Y-o-Y Growth Trend Analysis By Application, 2018-2022
    9.5. Absolute $ Opportunity Analysis By Application, 2023-2033
10. Global Research Antibodies & Reagents Market Analysis 2018-2022 and Forecast 2023-2033, By End User
    10.1. Introduction / Key Findings
    10.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018-2022
    10.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023-2033
        10.3.1. Pharmaceutical & Biotechnologies Industries
        10.3.2. Academic & Research Institutions
        10.3.3. Contract Research Organizations
    10.4. Y-o-Y Growth Trend Analysis By End User, 2018-2022
    10.5. Absolute $ Opportunity Analysis By End User, 2023-2033
11. Global Research Antibodies & Reagents Market Analysis 2018-2022 and Forecast 2023-2033, By Region
    11.1. Introduction
    11.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018-2022
    11.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023-2033
        11.3.1. North America
        11.3.2. Latin America
        11.3.3. Europe
        11.3.4. Asia Pacific
        11.3.5. Middle East and Africa
    11.4. Market Attractiveness Analysis By Region
12. North America Research Antibodies & Reagents Market Analysis 2018-2022 and Forecast 2023-2033, By Country
    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
        12.2.1. By Country
            12.2.1.1. U.S.
            12.2.1.2. Canada
        12.2.2. By Product
        12.2.3. By Form
        12.2.4. By Source
        12.2.5. By Technology
        12.2.6. By Application
        12.2.7. By End User
    12.3. Market Attractiveness Analysis
        12.3.1. By Country
        12.3.2. By Product
        12.3.3. By Form
        12.3.4. By Source
        12.3.5. By Technology
        12.3.6. By Application
        12.3.7. By End User
    12.4. Key Takeaways
13. Latin America Research Antibodies & Reagents Market Analysis 2018-2022 and Forecast 2023-2033, By Country
    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
        13.2.1. By Country
            13.2.1.1. Brazil
            13.2.1.2. Mexico
            13.2.1.3. Rest of Latin America
        13.2.2. By Product
        13.2.3. By Form
        13.2.4. By Source
        13.2.5. By Technology
        13.2.6. By Application
        13.2.7. By End User
    13.3. Market Attractiveness Analysis
        13.3.1. By Country
        13.3.2. By Product
        13.3.3. By Form
        13.3.4. By Source
        13.3.5. By Technology
        13.3.6. By Application
        13.3.7. By End User
    13.4. Key Takeaways
14. Europe Research Antibodies & Reagents Market Analysis 2018-2022 and Forecast 2023-2033, By Country
    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
        14.2.1. By Country
            14.2.1.1. U.K.
            14.2.1.2. Spain
            14.2.1.3. Germany
            14.2.1.4. Italy
            14.2.1.5. France
            14.2.1.6. Rest of Europe
        14.2.2. By Product
        14.2.3. By Form
        14.2.4. By Source
        14.2.5. By Technology
        14.2.6. By Application
        14.2.7. By End User
    14.3. Market Attractiveness Analysis
        14.3.1. By Country
        14.3.2. By Product
        14.3.3. By Form
        14.3.4. By Source
        14.3.5. By Technology
        14.3.6. By Application
        14.3.7. By End User
    14.4. Key Takeaways
15. Asia Pacific Research Antibodies & Reagents Market Analysis 2018-2022 and Forecast 2023-2033, By Country
    15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
    15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
        15.2.1. By Country
            15.2.1.1. India
            15.2.1.2. China
            15.2.1.3. Japan
            15.2.1.4. Rest of Asia Pacific
        15.2.2. By Product
        15.2.3. By Form
        15.2.4. By Source
        15.2.5. By Technology
        15.2.6. By Application
        15.2.7. By End User
    15.3. Market Attractiveness Analysis
        15.3.1. By Country
        15.3.2. By Product
        15.3.3. By Form
        15.3.4. By Source
        15.3.5. By Technology
        15.3.6. By Application
        15.3.7. By End User
    15.4. Key Takeaways
16. Middle East and Africa Research Antibodies & Reagents Market Analysis 2018-2022 and Forecast 2023-2033, By Country
    16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
    16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
        16.2.1. By Country
            16.2.1.1. South Africa
            16.2.1.2. GCC Countries
            16.2.1.3. Rest of Middle East and Africa
        16.2.2. By Product
        16.2.3. By Form
        16.2.4. By Source
        16.2.5. By Technology
        16.2.6. By Application
        16.2.7. By End User
    16.3. Market Attractiveness Analysis
        16.3.1. By Country
        16.3.2. By Product
        16.3.3. By Form
        16.3.4. By Source
        16.3.5. By Technology
        16.3.6. By Application
        16.3.7. By End User
    16.4. Key Takeaways
17. Key Countries Research Antibodies & Reagents Market Analysis
    17.1. U.S.
        17.1.1. Pricing Analysis
        17.1.2. Market Share Analysis, 2022
            17.1.2.1. By Product
            17.1.2.2. By Form
            17.1.2.3. By Source
            17.1.2.4. By Technology
            17.1.2.5. By Application
            17.1.2.6. By End User
    17.2. Canada
        17.2.1. Pricing Analysis
        17.2.2. Market Share Analysis, 2022
            17.2.2.1. By Product
            17.2.2.2. By Form
            17.2.2.3. By Source
            17.2.2.4. By Technology
            17.2.2.5. By Application
            17.2.2.6. By End User
    17.3. Brazil
        17.3.1. Pricing Analysis
        17.3.2. Market Share Analysis, 2022
            17.3.2.1. By Product
            17.3.2.2. By Form
            17.3.2.3. By Source
            17.3.2.4. By Technology
            17.3.2.5. By Application
            17.3.2.6. By End User
    17.4. Mexico
        17.4.1. Pricing Analysis
        17.4.2. Market Share Analysis, 2022
            17.4.2.1. By Product
            17.4.2.2. By Form
            17.4.2.3. By Source
            17.4.2.4. By Technology
            17.4.2.5. By Application
            17.4.2.6. By End User
    17.5. U.K.
        17.5.1. Pricing Analysis
        17.5.2. Market Share Analysis, 2022
            17.5.2.1. By Product
            17.5.2.2. By Form
            17.5.2.3. By Source
            17.5.2.4. By Technology
            17.5.2.5. By Application
            17.5.2.6. By End User
    17.6. Spain
        17.6.1. Pricing Analysis
        17.6.2. Market Share Analysis, 2022
            17.6.2.1. By Product
            17.6.2.2. By Form
            17.6.2.3. By Source
            17.6.2.4. By Technology
            17.6.2.5. By Application
            17.6.2.6. By End User
    17.7. Germany
        17.7.1. Pricing Analysis
        17.7.2. Market Share Analysis, 2022
            17.7.2.1. By Product
            17.7.2.2. By Form
            17.7.2.3. By Source
            17.7.2.4. By Technology
            17.7.2.5. By Application
            17.7.2.6. By End User
    17.8. Italy
        17.8.1. Pricing Analysis
        17.8.2. Market Share Analysis, 2022
            17.8.2.1. By Product
            17.8.2.2. By Form
            17.8.2.3. By Source
            17.8.2.4. By Technology
            17.8.2.5. By Application
            17.8.2.6. By End User
    17.9. France
        17.9.1. Pricing Analysis
        17.9.2. Market Share Analysis, 2022
            17.9.2.1. By Product
            17.9.2.2. By Form
            17.9.2.3. By Source
            17.9.2.4. By Technology
            17.9.2.5. By Application
            17.9.2.6. By End User
    17.10. India
        17.10.1. Pricing Analysis
        17.10.2. Market Share Analysis, 2022
            17.10.2.1. By Product
            17.10.2.2. By Form
            17.10.2.3. By Source
            17.10.2.4. By Technology
            17.10.2.5. By Application
            17.10.2.6. By End User
    17.11. China
        17.11.1. Pricing Analysis
        17.11.2. Market Share Analysis, 2022
            17.11.2.1. By Product
            17.11.2.2. By Form
            17.11.2.3. By Source
            17.11.2.4. By Technology
            17.11.2.5. By Application
            17.11.2.6. By End User
    17.12. Japan
        17.12.1. Pricing Analysis
        17.12.2. Market Share Analysis, 2022
            17.12.2.1. By Product
            17.12.2.2. By Form
            17.12.2.3. By Source
            17.12.2.4. By Technology
            17.12.2.5. By Application
            17.12.2.6. By End User
    17.13. Australia & New Zealand
        17.13.1. Pricing Analysis
        17.13.2. Market Share Analysis, 2022
            17.13.2.1. By Product
            17.13.2.2. By Form
            17.13.2.3. By Source
            17.13.2.4. By Technology
            17.13.2.5. By Application
            17.13.2.6. By End User
    17.14. South Africa
        17.14.1. Pricing Analysis
        17.14.2. Market Share Analysis, 2022
            17.14.2.1. By Product
            17.14.2.2. By Form
            17.14.2.3. By Source
            17.14.2.4. By Technology
            17.14.2.5. By Application
            17.14.2.6. By End User
    17.15. GCC Countries
        17.15.1. Pricing Analysis
        17.15.2. Market Share Analysis, 2022
            17.15.2.1. By Product
            17.15.2.2. By Form
            17.15.2.3. By Source
            17.15.2.4. By Technology
            17.15.2.5. By Application
            17.15.2.6. By End User
18. Market Structure Analysis
    18.1. Competition Dashboard
    18.2. Competition Benchmarking
    18.3. Market Share Analysis of Top Players
        18.3.1. By Regional
        18.3.2. By Product
        18.3.3. By Form
        18.3.4. By Source
        18.3.5. By Technology
        18.3.6. By Application
        18.3.7. By End User
19. Competition Analysis
    19.1. Competition Deep Dive
        19.1.1. Thermo Fisher Scientific, Inc.
            19.1.1.1. Overview
            19.1.1.2. Product Portfolio
            19.1.1.3. Profitability by Market Segments
            19.1.1.4. Sales Footprint
            19.1.1.5. Strategy Overview
                19.1.1.5.1. Marketing Strategy
        19.1.2. Merck KGaA
            19.1.2.1. Overview
            19.1.2.2. Product Portfolio
            19.1.2.3. Profitability by Market Segments
            19.1.2.4. Sales Footprint
            19.1.2.5. Strategy Overview
                19.1.2.5.1. Marketing Strategy
        19.1.3. Abcam Plc
            19.1.3.1. Overview
            19.1.3.2. Product Portfolio
            19.1.3.3. Profitability by Market Segments
            19.1.3.4. Sales Footprint
            19.1.3.5. Strategy Overview
                19.1.3.5.1. Marketing Strategy
        19.1.4. Becton, Dickinson and Company
            19.1.4.1. Overview
            19.1.4.2. Product Portfolio
            19.1.4.3. Profitability by Market Segments
            19.1.4.4. Sales Footprint
            19.1.4.5. Strategy Overview
                19.1.4.5.1. Marketing Strategy
        19.1.5. Bio-Rad Laboratories
            19.1.5.1. Overview
            19.1.5.2. Product Portfolio
            19.1.5.3. Profitability by Market Segments
            19.1.5.4. Sales Footprint
            19.1.5.5. Strategy Overview
                19.1.5.5.1. Marketing Strategy
        19.1.6. Cell Signaling Technologies
            19.1.6.1. Overview
            19.1.6.2. Product Portfolio
            19.1.6.3. Profitability by Market Segments
            19.1.6.4. Sales Footprint
            19.1.6.5. Strategy Overview
                19.1.6.5.1. Marketing Strategy
        19.1.7. F. Hoffman-La Roche
            19.1.7.1. Overview
            19.1.7.2. Product Portfolio
            19.1.7.3. Profitability by Market Segments
            19.1.7.4. Sales Footprint
            19.1.7.5. Strategy Overview
                19.1.7.5.1. Marketing Strategy
        19.1.8. Danaher Corporation
            19.1.8.1. Overview
            19.1.8.2. Product Portfolio
            19.1.8.3. Profitability by Market Segments
            19.1.8.4. Sales Footprint
            19.1.8.5. Strategy Overview
                19.1.8.5.1. Marketing Strategy
        19.1.9. Agilent Technologies
            19.1.9.1. Overview
            19.1.9.2. Product Portfolio
            19.1.9.3. Profitability by Market Segments
            19.1.9.4. Sales Footprint
            19.1.9.5. Strategy Overview
                19.1.9.5.1. Marketing Strategy
        19.1.10. PerkinElmer
            19.1.10.1. Overview
            19.1.10.2. Product Portfolio
            19.1.10.3. Profitability by Market Segments
            19.1.10.4. Sales Footprint
            19.1.10.5. Strategy Overview
                19.1.10.5.1. Marketing Strategy
        19.1.11. Lonza
            19.1.11.1. Overview
            19.1.11.2. Product Portfolio
            19.1.11.3. Profitability by Market Segments
            19.1.11.4. Sales Footprint
            19.1.11.5. Strategy Overview
                19.1.11.5.1. Marketing Strategy
        19.1.12. GenScript
            19.1.12.1. Overview
            19.1.12.2. Product Portfolio
            19.1.12.3. Profitability by Market Segments
            19.1.12.4. Sales Footprint
            19.1.12.5. Strategy Overview
                19.1.12.5.1. Marketing Strategy
        19.1.13. BioLegend
            19.1.13.1. Overview
            19.1.13.2. Product Portfolio
            19.1.13.3. Profitability by Market Segments
            19.1.13.4. Sales Footprint
            19.1.13.5. Strategy Overview
                19.1.13.5.1. Marketing Strategy
        19.1.14. Illumina, Inc.
            19.1.14.1. Overview
            19.1.14.2. Product Portfolio
            19.1.14.3. Profitability by Market Segments
            19.1.14.4. Sales Footprint
            19.1.14.5. Strategy Overview
                19.1.14.5.1. Marketing Strategy
        19.1.15. Fujirebio Diagnostics, Inc
            19.1.15.1. Overview
            19.1.15.2. Product Portfolio
            19.1.15.3. Profitability by Market Segments
            19.1.15.4. Sales Footprint
            19.1.15.5. Strategy Overview
                19.1.15.5.1. Marketing Strategy
20. Assumptions & Acronyms Used
21. Research Methodology

ページTOPに戻る



図表リスト

List of Tables

Table 1: Global Research Antibodies & Reagents Market Value (US$ Million) Forecast by Region, 2018-2033

Table 2: Global Research Antibodies & Reagents Market Value (US$ Million) Forecast by Product, 2018-2033

Table 3: Global Research Antibodies & Reagents Market Value (US$ Million) Forecast by Form, 2018-2033

Table 4: Global Research Antibodies & Reagents Market Value (US$ Million) Forecast by Source , 2018-2033

Table 5: Global Research Antibodies & Reagents Market Value (US$ Million) Forecast by Technology, 2018-2033

Table 6: Global Research Antibodies & Reagents Market Value (US$ Million) Forecast by Application, 2018-2033

Table 7: Global Research Antibodies & Reagents Market Value (US$ Million) Forecast by End User, 2018-2033

Table 8: North America Research Antibodies & Reagents Market Value (US$ Million) Forecast by Country, 2018-2033

Table 9: North America Research Antibodies & Reagents Market Value (US$ Million) Forecast by Product, 2018-2033

Table 10: North America Research Antibodies & Reagents Market Value (US$ Million) Forecast by Form, 2018-2033

Table 11: North America Research Antibodies & Reagents Market Value (US$ Million) Forecast by Source , 2018-2033

Table 12: North America Research Antibodies & Reagents Market Value (US$ Million) Forecast by Technology, 2018-2033

Table 13: North America Research Antibodies & Reagents Market Value (US$ Million) Forecast by Application, 2018-2033

Table 14: North America Research Antibodies & Reagents Market Value (US$ Million) Forecast by End User, 2018-2033

Table 15: Latin America Research Antibodies & Reagents Market Value (US$ Million) Forecast by Country, 2018-2033

Table 16: Latin America Research Antibodies & Reagents Market Value (US$ Million) Forecast by Product, 2018-2033

Table 17: Latin America Research Antibodies & Reagents Market Value (US$ Million) Forecast by Form, 2018-2033

Table 18: Latin America Research Antibodies & Reagents Market Value (US$ Million) Forecast by Source , 2018-2033

Table 19: Latin America Research Antibodies & Reagents Market Value (US$ Million) Forecast by Technology, 2018-2033

Table 20: Latin America Research Antibodies & Reagents Market Value (US$ Million) Forecast by Application, 2018-2033

Table 21: Latin America Research Antibodies & Reagents Market Value (US$ Million) Forecast by End User, 2018-2033

Table 22: Europe Research Antibodies & Reagents Market Value (US$ Million) Forecast by Country, 2018-2033

Table 23: Europe Research Antibodies & Reagents Market Value (US$ Million) Forecast by Product, 2018-2033

Table 24: Europe Research Antibodies & Reagents Market Value (US$ Million) Forecast by Form, 2018-2033

Table 25: Europe Research Antibodies & Reagents Market Value (US$ Million) Forecast by Source , 2018-2033

Table 26: Europe Research Antibodies & Reagents Market Value (US$ Million) Forecast by Technology, 2018-2033

Table 27: Europe Research Antibodies & Reagents Market Value (US$ Million) Forecast by Application, 2018-2033

Table 28: Europe Research Antibodies & Reagents Market Value (US$ Million) Forecast by End User, 2018-2033

Table 29: Asia Pacific Research Antibodies & Reagents Market Value (US$ Million) Forecast by Country, 2018-2033

Table 30: Asia Pacific Research Antibodies & Reagents Market Value (US$ Million) Forecast by Product, 2018-2033

Table 31: Asia Pacific Research Antibodies & Reagents Market Value (US$ Million) Forecast by Form, 2018-2033

Table 32: Asia Pacific Research Antibodies & Reagents Market Value (US$ Million) Forecast by Source , 2018-2033

Table 33: Asia Pacific Research Antibodies & Reagents Market Value (US$ Million) Forecast by Technology, 2018-2033

Table 34: Asia Pacific Research Antibodies & Reagents Market Value (US$ Million) Forecast by Application, 2018-2033

Table 35: Asia Pacific Research Antibodies & Reagents Market Value (US$ Million) Forecast by End User, 2018-2033

Table 36: Middle East and Africa Research Antibodies & Reagents Market Value (US$ Million) Forecast by Country, 2018-2033

Table 37: Middle East and Africa Research Antibodies & Reagents Market Value (US$ Million) Forecast by Product, 2018-2033

Table 38: Middle East and Africa Research Antibodies & Reagents Market Value (US$ Million) Forecast by Form, 2018-2033

Table 39: Middle East and Africa Research Antibodies & Reagents Market Value (US$ Million) Forecast by Source , 2018-2033

Table 40: Middle East and Africa Research Antibodies & Reagents Market Value (US$ Million) Forecast by Technology, 2018-2033

Table 41: Middle East and Africa Research Antibodies & Reagents Market Value (US$ Million) Forecast by Application, 2018-2033

Table 42: Middle East and Africa Research Antibodies & Reagents Market Value (US$ Million) Forecast by End User, 2018-2033

 

ページTOPに戻る


 

Summary

Research Antibodies and Reagents Market – Scope of Report
TMR’s report on the global research antibodies and reagents market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2033. The report provides revenue of the global research antibodies and reagents market for the period 2017–2033, considering 2023 as the base year and 2033 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global research antibodies and reagents market from 2023 to 2033.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the research antibodies and reagents market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global research antibodies and reagents market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global research antibodies and reagents market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global research antibodies and reagents market.

The report delves into the competitive landscape of the global research antibodies and reagents market. Key players operating in the global research antibodies and reagents market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global research antibodies and reagents market profiled in this report.

Key Questions Answered in Global Research Antibodies and Reagents Market Report
• What is the sales/revenue generated by research antibodies and reagents across all regions during the forecast period?
• What are the opportunities in the global research antibodies and reagents market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2033?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Research Antibodies and Reagents Market – Research Objectives and Research Approach
The comprehensive report on the global research antibodies and reagents market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global research antibodies and reagents market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2033 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global research antibodies and reagents market.



ページTOPに戻る


Table of Contents

1. Executive Summary
    1.1. Global Market Outlook
    1.2. Demand-side Trends
    1.3. Supply-side Trends
    1.4. Technology Roadmap Analysis
    1.5. Analysis and Recommendations
2. Market Overview
    2.1. Market Coverage / Taxonomy
    2.2. Market Definition / Scope / Limitations
3. Market Background
    3.1. Market Dynamics
        3.1.1. Drivers
        3.1.2. Restraints
        3.1.3. Opportunity
        3.1.4. Trends
    3.2. Scenario Forecast
        3.2.1. Demand in Optimistic Scenario
        3.2.2. Demand in Likely Scenario
        3.2.3. Demand in Conservative Scenario
    3.3. Opportunity Map Analysis
    3.4. Investment Feasibility Matrix
    3.5. PESTLE and Porter’s Analysis
    3.6. Regulatory Landscape
        3.6.1. By Key Regions
        3.6.2. By Key Countries
    3.7. Regional Parent Market Outlook
4. Global Research Antibodies & Reagents Market Analysis 2018-2022 and Forecast, 2023-2033
    4.1. Historical Market Size Value (US$ Million) Analysis, 2018-2022
    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023-2033
        4.2.1. Y-o-Y Growth Trend Analysis
        4.2.2. Absolute $ Opportunity Analysis
5. Global Research Antibodies & Reagents Market Analysis 2018-2022 and Forecast 2023-2033, By Product
    5.1. Introduction / Key Findings
    5.2. Historical Market Size Value (US$ Million) Analysis By Product, 2018-2022
    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2023-2033
        5.3.1. Reagent
            5.3.1.1. Media & Sera
            5.3.1.2. Stains & Dyes
            5.3.1.3. Fixatives
            5.3.1.4. Buffers
            5.3.1.5. Solvents
            5.3.1.6. Enzymes
            5.3.1.7. Probes
            5.3.1.8. Other Reagents
        5.3.2. Antibodies
            5.3.2.1. Primary Antibodies
            5.3.2.2. Secondary Antibodies
    5.4. Y-o-Y Growth Trend Analysis By Product, 2018-2022
    5.5. Absolute $ Opportunity Analysis By Product, 2023-2033
6. Global Research Antibodies & Reagents Market Analysis 2018-2022 and Forecast 2023-2033, By Form
    6.1. Introduction / Key Findings
    6.2. Historical Market Size Value (US$ Million) Analysis By Form, 2018-2022
    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Form, 2023-2033
        6.3.1. Monoclonal Antibodies
        6.3.2. Polyclonal Antibodies
        6.3.3. Recombinant Antibodies
    6.4. Y-o-Y Growth Trend Analysis By Form, 2018-2022
    6.5. Absolute $ Opportunity Analysis By Form, 2023-2033
7. Global Research Antibodies & Reagents Market Analysis 2018-2022 and Forecast 2023-2033, By Source
    7.1. Introduction / Key Findings
    7.2. Historical Market Size Value (US$ Million) Analysis By Source , 2018-2022
    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Source , 2023-2033
        7.3.1. Mice
        7.3.2. Rabbit
        7.3.3. Other Sources
    7.4. Y-o-Y Growth Trend Analysis By Source , 2018-2022
    7.5. Absolute $ Opportunity Analysis By Source , 2023-2033
8. Global Research Antibodies & Reagents Market Analysis 2018-2022 and Forecast 2023-2033, By Technology
    8.1. Introduction / Key Findings
    8.2. Historical Market Size Value (US$ Million) Analysis By Technology, 2018-2022
    8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Technology, 2023-2033
        8.3.1. Weatern Blotting
        8.3.2. Flow Cytometry
        8.3.3. Enzyme-linked Immunosorbent Assay
        8.3.4. Immunohistochemistry
        8.3.5. Immunofluorescence
        8.3.6. Immunoprecipitation
        8.3.7. Other Technologies
    8.4. Y-o-Y Growth Trend Analysis By Technology, 2018-2022
    8.5. Absolute $ Opportunity Analysis By Technology, 2023-2033
9. Global Research Antibodies & Reagents Market Analysis 2018-2022 and Forecast 2023-2033, By Application
    9.1. Introduction / Key Findings
    9.2. Historical Market Size Value (US$ Million) Analysis By Application, 2018-2022
    9.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2023-2033
        9.3.1. Proteomics
        9.3.2. Drug Development
        9.3.3. Genomics
    9.4. Y-o-Y Growth Trend Analysis By Application, 2018-2022
    9.5. Absolute $ Opportunity Analysis By Application, 2023-2033
10. Global Research Antibodies & Reagents Market Analysis 2018-2022 and Forecast 2023-2033, By End User
    10.1. Introduction / Key Findings
    10.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018-2022
    10.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023-2033
        10.3.1. Pharmaceutical & Biotechnologies Industries
        10.3.2. Academic & Research Institutions
        10.3.3. Contract Research Organizations
    10.4. Y-o-Y Growth Trend Analysis By End User, 2018-2022
    10.5. Absolute $ Opportunity Analysis By End User, 2023-2033
11. Global Research Antibodies & Reagents Market Analysis 2018-2022 and Forecast 2023-2033, By Region
    11.1. Introduction
    11.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018-2022
    11.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023-2033
        11.3.1. North America
        11.3.2. Latin America
        11.3.3. Europe
        11.3.4. Asia Pacific
        11.3.5. Middle East and Africa
    11.4. Market Attractiveness Analysis By Region
12. North America Research Antibodies & Reagents Market Analysis 2018-2022 and Forecast 2023-2033, By Country
    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
        12.2.1. By Country
            12.2.1.1. U.S.
            12.2.1.2. Canada
        12.2.2. By Product
        12.2.3. By Form
        12.2.4. By Source
        12.2.5. By Technology
        12.2.6. By Application
        12.2.7. By End User
    12.3. Market Attractiveness Analysis
        12.3.1. By Country
        12.3.2. By Product
        12.3.3. By Form
        12.3.4. By Source
        12.3.5. By Technology
        12.3.6. By Application
        12.3.7. By End User
    12.4. Key Takeaways
13. Latin America Research Antibodies & Reagents Market Analysis 2018-2022 and Forecast 2023-2033, By Country
    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
        13.2.1. By Country
            13.2.1.1. Brazil
            13.2.1.2. Mexico
            13.2.1.3. Rest of Latin America
        13.2.2. By Product
        13.2.3. By Form
        13.2.4. By Source
        13.2.5. By Technology
        13.2.6. By Application
        13.2.7. By End User
    13.3. Market Attractiveness Analysis
        13.3.1. By Country
        13.3.2. By Product
        13.3.3. By Form
        13.3.4. By Source
        13.3.5. By Technology
        13.3.6. By Application
        13.3.7. By End User
    13.4. Key Takeaways
14. Europe Research Antibodies & Reagents Market Analysis 2018-2022 and Forecast 2023-2033, By Country
    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
        14.2.1. By Country
            14.2.1.1. U.K.
            14.2.1.2. Spain
            14.2.1.3. Germany
            14.2.1.4. Italy
            14.2.1.5. France
            14.2.1.6. Rest of Europe
        14.2.2. By Product
        14.2.3. By Form
        14.2.4. By Source
        14.2.5. By Technology
        14.2.6. By Application
        14.2.7. By End User
    14.3. Market Attractiveness Analysis
        14.3.1. By Country
        14.3.2. By Product
        14.3.3. By Form
        14.3.4. By Source
        14.3.5. By Technology
        14.3.6. By Application
        14.3.7. By End User
    14.4. Key Takeaways
15. Asia Pacific Research Antibodies & Reagents Market Analysis 2018-2022 and Forecast 2023-2033, By Country
    15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
    15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
        15.2.1. By Country
            15.2.1.1. India
            15.2.1.2. China
            15.2.1.3. Japan
            15.2.1.4. Rest of Asia Pacific
        15.2.2. By Product
        15.2.3. By Form
        15.2.4. By Source
        15.2.5. By Technology
        15.2.6. By Application
        15.2.7. By End User
    15.3. Market Attractiveness Analysis
        15.3.1. By Country
        15.3.2. By Product
        15.3.3. By Form
        15.3.4. By Source
        15.3.5. By Technology
        15.3.6. By Application
        15.3.7. By End User
    15.4. Key Takeaways
16. Middle East and Africa Research Antibodies & Reagents Market Analysis 2018-2022 and Forecast 2023-2033, By Country
    16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
    16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
        16.2.1. By Country
            16.2.1.1. South Africa
            16.2.1.2. GCC Countries
            16.2.1.3. Rest of Middle East and Africa
        16.2.2. By Product
        16.2.3. By Form
        16.2.4. By Source
        16.2.5. By Technology
        16.2.6. By Application
        16.2.7. By End User
    16.3. Market Attractiveness Analysis
        16.3.1. By Country
        16.3.2. By Product
        16.3.3. By Form
        16.3.4. By Source
        16.3.5. By Technology
        16.3.6. By Application
        16.3.7. By End User
    16.4. Key Takeaways
17. Key Countries Research Antibodies & Reagents Market Analysis
    17.1. U.S.
        17.1.1. Pricing Analysis
        17.1.2. Market Share Analysis, 2022
            17.1.2.1. By Product
            17.1.2.2. By Form
            17.1.2.3. By Source
            17.1.2.4. By Technology
            17.1.2.5. By Application
            17.1.2.6. By End User
    17.2. Canada
        17.2.1. Pricing Analysis
        17.2.2. Market Share Analysis, 2022
            17.2.2.1. By Product
            17.2.2.2. By Form
            17.2.2.3. By Source
            17.2.2.4. By Technology
            17.2.2.5. By Application
            17.2.2.6. By End User
    17.3. Brazil
        17.3.1. Pricing Analysis
        17.3.2. Market Share Analysis, 2022
            17.3.2.1. By Product
            17.3.2.2. By Form
            17.3.2.3. By Source
            17.3.2.4. By Technology
            17.3.2.5. By Application
            17.3.2.6. By End User
    17.4. Mexico
        17.4.1. Pricing Analysis
        17.4.2. Market Share Analysis, 2022
            17.4.2.1. By Product
            17.4.2.2. By Form
            17.4.2.3. By Source
            17.4.2.4. By Technology
            17.4.2.5. By Application
            17.4.2.6. By End User
    17.5. U.K.
        17.5.1. Pricing Analysis
        17.5.2. Market Share Analysis, 2022
            17.5.2.1. By Product
            17.5.2.2. By Form
            17.5.2.3. By Source
            17.5.2.4. By Technology
            17.5.2.5. By Application
            17.5.2.6. By End User
    17.6. Spain
        17.6.1. Pricing Analysis
        17.6.2. Market Share Analysis, 2022
            17.6.2.1. By Product
            17.6.2.2. By Form
            17.6.2.3. By Source
            17.6.2.4. By Technology
            17.6.2.5. By Application
            17.6.2.6. By End User
    17.7. Germany
        17.7.1. Pricing Analysis
        17.7.2. Market Share Analysis, 2022
            17.7.2.1. By Product
            17.7.2.2. By Form
            17.7.2.3. By Source
            17.7.2.4. By Technology
            17.7.2.5. By Application
            17.7.2.6. By End User
    17.8. Italy
        17.8.1. Pricing Analysis
        17.8.2. Market Share Analysis, 2022
            17.8.2.1. By Product
            17.8.2.2. By Form
            17.8.2.3. By Source
            17.8.2.4. By Technology
            17.8.2.5. By Application
            17.8.2.6. By End User
    17.9. France
        17.9.1. Pricing Analysis
        17.9.2. Market Share Analysis, 2022
            17.9.2.1. By Product
            17.9.2.2. By Form
            17.9.2.3. By Source
            17.9.2.4. By Technology
            17.9.2.5. By Application
            17.9.2.6. By End User
    17.10. India
        17.10.1. Pricing Analysis
        17.10.2. Market Share Analysis, 2022
            17.10.2.1. By Product
            17.10.2.2. By Form
            17.10.2.3. By Source
            17.10.2.4. By Technology
            17.10.2.5. By Application
            17.10.2.6. By End User
    17.11. China
        17.11.1. Pricing Analysis
        17.11.2. Market Share Analysis, 2022
            17.11.2.1. By Product
            17.11.2.2. By Form
            17.11.2.3. By Source
            17.11.2.4. By Technology
            17.11.2.5. By Application
            17.11.2.6. By End User
    17.12. Japan
        17.12.1. Pricing Analysis
        17.12.2. Market Share Analysis, 2022
            17.12.2.1. By Product
            17.12.2.2. By Form
            17.12.2.3. By Source
            17.12.2.4. By Technology
            17.12.2.5. By Application
            17.12.2.6. By End User
    17.13. Australia & New Zealand
        17.13.1. Pricing Analysis
        17.13.2. Market Share Analysis, 2022
            17.13.2.1. By Product
            17.13.2.2. By Form
            17.13.2.3. By Source
            17.13.2.4. By Technology
            17.13.2.5. By Application
            17.13.2.6. By End User
    17.14. South Africa
        17.14.1. Pricing Analysis
        17.14.2. Market Share Analysis, 2022
            17.14.2.1. By Product
            17.14.2.2. By Form
            17.14.2.3. By Source
            17.14.2.4. By Technology
            17.14.2.5. By Application
            17.14.2.6. By End User
    17.15. GCC Countries
        17.15.1. Pricing Analysis
        17.15.2. Market Share Analysis, 2022
            17.15.2.1. By Product
            17.15.2.2. By Form
            17.15.2.3. By Source
            17.15.2.4. By Technology
            17.15.2.5. By Application
            17.15.2.6. By End User
18. Market Structure Analysis
    18.1. Competition Dashboard
    18.2. Competition Benchmarking
    18.3. Market Share Analysis of Top Players
        18.3.1. By Regional
        18.3.2. By Product
        18.3.3. By Form
        18.3.4. By Source
        18.3.5. By Technology
        18.3.6. By Application
        18.3.7. By End User
19. Competition Analysis
    19.1. Competition Deep Dive
        19.1.1. Thermo Fisher Scientific, Inc.
            19.1.1.1. Overview
            19.1.1.2. Product Portfolio
            19.1.1.3. Profitability by Market Segments
            19.1.1.4. Sales Footprint
            19.1.1.5. Strategy Overview
                19.1.1.5.1. Marketing Strategy
        19.1.2. Merck KGaA
            19.1.2.1. Overview
            19.1.2.2. Product Portfolio
            19.1.2.3. Profitability by Market Segments
            19.1.2.4. Sales Footprint
            19.1.2.5. Strategy Overview
                19.1.2.5.1. Marketing Strategy
        19.1.3. Abcam Plc
            19.1.3.1. Overview
            19.1.3.2. Product Portfolio
            19.1.3.3. Profitability by Market Segments
            19.1.3.4. Sales Footprint
            19.1.3.5. Strategy Overview
                19.1.3.5.1. Marketing Strategy
        19.1.4. Becton, Dickinson and Company
            19.1.4.1. Overview
            19.1.4.2. Product Portfolio
            19.1.4.3. Profitability by Market Segments
            19.1.4.4. Sales Footprint
            19.1.4.5. Strategy Overview
                19.1.4.5.1. Marketing Strategy
        19.1.5. Bio-Rad Laboratories
            19.1.5.1. Overview
            19.1.5.2. Product Portfolio
            19.1.5.3. Profitability by Market Segments
            19.1.5.4. Sales Footprint
            19.1.5.5. Strategy Overview
                19.1.5.5.1. Marketing Strategy
        19.1.6. Cell Signaling Technologies
            19.1.6.1. Overview
            19.1.6.2. Product Portfolio
            19.1.6.3. Profitability by Market Segments
            19.1.6.4. Sales Footprint
            19.1.6.5. Strategy Overview
                19.1.6.5.1. Marketing Strategy
        19.1.7. F. Hoffman-La Roche
            19.1.7.1. Overview
            19.1.7.2. Product Portfolio
            19.1.7.3. Profitability by Market Segments
            19.1.7.4. Sales Footprint
            19.1.7.5. Strategy Overview
                19.1.7.5.1. Marketing Strategy
        19.1.8. Danaher Corporation
            19.1.8.1. Overview
            19.1.8.2. Product Portfolio
            19.1.8.3. Profitability by Market Segments
            19.1.8.4. Sales Footprint
            19.1.8.5. Strategy Overview
                19.1.8.5.1. Marketing Strategy
        19.1.9. Agilent Technologies
            19.1.9.1. Overview
            19.1.9.2. Product Portfolio
            19.1.9.3. Profitability by Market Segments
            19.1.9.4. Sales Footprint
            19.1.9.5. Strategy Overview
                19.1.9.5.1. Marketing Strategy
        19.1.10. PerkinElmer
            19.1.10.1. Overview
            19.1.10.2. Product Portfolio
            19.1.10.3. Profitability by Market Segments
            19.1.10.4. Sales Footprint
            19.1.10.5. Strategy Overview
                19.1.10.5.1. Marketing Strategy
        19.1.11. Lonza
            19.1.11.1. Overview
            19.1.11.2. Product Portfolio
            19.1.11.3. Profitability by Market Segments
            19.1.11.4. Sales Footprint
            19.1.11.5. Strategy Overview
                19.1.11.5.1. Marketing Strategy
        19.1.12. GenScript
            19.1.12.1. Overview
            19.1.12.2. Product Portfolio
            19.1.12.3. Profitability by Market Segments
            19.1.12.4. Sales Footprint
            19.1.12.5. Strategy Overview
                19.1.12.5.1. Marketing Strategy
        19.1.13. BioLegend
            19.1.13.1. Overview
            19.1.13.2. Product Portfolio
            19.1.13.3. Profitability by Market Segments
            19.1.13.4. Sales Footprint
            19.1.13.5. Strategy Overview
                19.1.13.5.1. Marketing Strategy
        19.1.14. Illumina, Inc.
            19.1.14.1. Overview
            19.1.14.2. Product Portfolio
            19.1.14.3. Profitability by Market Segments
            19.1.14.4. Sales Footprint
            19.1.14.5. Strategy Overview
                19.1.14.5.1. Marketing Strategy
        19.1.15. Fujirebio Diagnostics, Inc
            19.1.15.1. Overview
            19.1.15.2. Product Portfolio
            19.1.15.3. Profitability by Market Segments
            19.1.15.4. Sales Footprint
            19.1.15.5. Strategy Overview
                19.1.15.5.1. Marketing Strategy
20. Assumptions & Acronyms Used
21. Research Methodology

ページTOPに戻る



List of Tables/Graphs

List of Tables

Table 1: Global Research Antibodies & Reagents Market Value (US$ Million) Forecast by Region, 2018-2033

Table 2: Global Research Antibodies & Reagents Market Value (US$ Million) Forecast by Product, 2018-2033

Table 3: Global Research Antibodies & Reagents Market Value (US$ Million) Forecast by Form, 2018-2033

Table 4: Global Research Antibodies & Reagents Market Value (US$ Million) Forecast by Source , 2018-2033

Table 5: Global Research Antibodies & Reagents Market Value (US$ Million) Forecast by Technology, 2018-2033

Table 6: Global Research Antibodies & Reagents Market Value (US$ Million) Forecast by Application, 2018-2033

Table 7: Global Research Antibodies & Reagents Market Value (US$ Million) Forecast by End User, 2018-2033

Table 8: North America Research Antibodies & Reagents Market Value (US$ Million) Forecast by Country, 2018-2033

Table 9: North America Research Antibodies & Reagents Market Value (US$ Million) Forecast by Product, 2018-2033

Table 10: North America Research Antibodies & Reagents Market Value (US$ Million) Forecast by Form, 2018-2033

Table 11: North America Research Antibodies & Reagents Market Value (US$ Million) Forecast by Source , 2018-2033

Table 12: North America Research Antibodies & Reagents Market Value (US$ Million) Forecast by Technology, 2018-2033

Table 13: North America Research Antibodies & Reagents Market Value (US$ Million) Forecast by Application, 2018-2033

Table 14: North America Research Antibodies & Reagents Market Value (US$ Million) Forecast by End User, 2018-2033

Table 15: Latin America Research Antibodies & Reagents Market Value (US$ Million) Forecast by Country, 2018-2033

Table 16: Latin America Research Antibodies & Reagents Market Value (US$ Million) Forecast by Product, 2018-2033

Table 17: Latin America Research Antibodies & Reagents Market Value (US$ Million) Forecast by Form, 2018-2033

Table 18: Latin America Research Antibodies & Reagents Market Value (US$ Million) Forecast by Source , 2018-2033

Table 19: Latin America Research Antibodies & Reagents Market Value (US$ Million) Forecast by Technology, 2018-2033

Table 20: Latin America Research Antibodies & Reagents Market Value (US$ Million) Forecast by Application, 2018-2033

Table 21: Latin America Research Antibodies & Reagents Market Value (US$ Million) Forecast by End User, 2018-2033

Table 22: Europe Research Antibodies & Reagents Market Value (US$ Million) Forecast by Country, 2018-2033

Table 23: Europe Research Antibodies & Reagents Market Value (US$ Million) Forecast by Product, 2018-2033

Table 24: Europe Research Antibodies & Reagents Market Value (US$ Million) Forecast by Form, 2018-2033

Table 25: Europe Research Antibodies & Reagents Market Value (US$ Million) Forecast by Source , 2018-2033

Table 26: Europe Research Antibodies & Reagents Market Value (US$ Million) Forecast by Technology, 2018-2033

Table 27: Europe Research Antibodies & Reagents Market Value (US$ Million) Forecast by Application, 2018-2033

Table 28: Europe Research Antibodies & Reagents Market Value (US$ Million) Forecast by End User, 2018-2033

Table 29: Asia Pacific Research Antibodies & Reagents Market Value (US$ Million) Forecast by Country, 2018-2033

Table 30: Asia Pacific Research Antibodies & Reagents Market Value (US$ Million) Forecast by Product, 2018-2033

Table 31: Asia Pacific Research Antibodies & Reagents Market Value (US$ Million) Forecast by Form, 2018-2033

Table 32: Asia Pacific Research Antibodies & Reagents Market Value (US$ Million) Forecast by Source , 2018-2033

Table 33: Asia Pacific Research Antibodies & Reagents Market Value (US$ Million) Forecast by Technology, 2018-2033

Table 34: Asia Pacific Research Antibodies & Reagents Market Value (US$ Million) Forecast by Application, 2018-2033

Table 35: Asia Pacific Research Antibodies & Reagents Market Value (US$ Million) Forecast by End User, 2018-2033

Table 36: Middle East and Africa Research Antibodies & Reagents Market Value (US$ Million) Forecast by Country, 2018-2033

Table 37: Middle East and Africa Research Antibodies & Reagents Market Value (US$ Million) Forecast by Product, 2018-2033

Table 38: Middle East and Africa Research Antibodies & Reagents Market Value (US$ Million) Forecast by Form, 2018-2033

Table 39: Middle East and Africa Research Antibodies & Reagents Market Value (US$ Million) Forecast by Source , 2018-2033

Table 40: Middle East and Africa Research Antibodies & Reagents Market Value (US$ Million) Forecast by Technology, 2018-2033

Table 41: Middle East and Africa Research Antibodies & Reagents Market Value (US$ Million) Forecast by Application, 2018-2033

Table 42: Middle East and Africa Research Antibodies & Reagents Market Value (US$ Million) Forecast by End User, 2018-2033

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

Transparency Market Research社の医療分野での最新刊レポート

本レポートと同じKEY WORD(antibodies)の最新刊レポート


よくあるご質問


Transparency Market Research社はどのような調査会社ですか?


トレンスペアレンシーマーケットリサーチ(Transparency Market Research /TMR)は市場参入やホワイトスペースの特定、新商品や新サービスの立ち上げ、戦略的M&Aなどの実現のた... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/15 10:26

157.84 円

166.62 円

202.61 円

ページTOPに戻る